BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results

Strategic acquisition and strong margins help offset market pressures and position BioStem for renewed growth in 2026 POMPANO BEACH, FL, March 24, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft […]

The post BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results first appeared on Prism Media Wire.